GE Healthcare (US) and Becton, Dickinson and Company (US) are the Key Players in the Cancer Diagnostics Market
The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR 11.5% from 2021 to 2026. The growth of this market is driven by rising prevalence of cancer, and growing initiatives undertaken by government bodies to create awareness about cancer, the increasing number of private diagnostic centers.
The cancer diagnostics market is highly consolidated and is dominated by various players. The major players operating in this market are Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Fujifilm Corporation (Japan), Aglient Technologies (US) and Thermo Fisher Scientific Inc. (US) etc.
To know about the assumptions considered for the study download the pdf brochure
GE Healthcare (US)
GE Healthcare (US) held the leading position in the cancer diagnostics market (Imaging Based products) in 2021. GE Healthcare offers an exhaustive product portfolio consisting of various cancer diagnostics products. The company believes in both organic and inorganic growth for enhancing its market position such product launches, and partnership. For instance, in 2020, GE Healthcare entered into partnership with GenesisCare to improve patient outcomes for the two biggest health burdens globally, cancer and heart disease. GE Healthcare will provide CT, MRI, PET/CT, SPECT, digital mammography, and ultrasound equipment to GenesisCare’s 440+ cancer and cardiovascular disease treatment centers across Australia, the US, the UK, and Spain.
Becton, Dickinson and Company (US)
BD (US) accounted for the second-largest share of the global cancer diagnostics market (Pathology Based products) in 2020. The company provides its radiation dowing to its robust portfolio of cancer diagnostics products and efforts to develop innovative products by investing in R&D. With a strong footprint across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific, as well as numerous subsidiaries and distribution channels,
Related Reports:
Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) - Global Forecasts to 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
